| 20th Aug 2018 7:00 am |
RNS |
Block listing Interim Review |
| 15th Aug 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 14th Aug 2018 7:10 am |
RNS |
Half-year Report |
| 8th Aug 2018 7:00 am |
RNS |
Presents at Wedbush PacGrow Healthcare Conference |
| 7th Aug 2018 7:00 am |
RNS |
Notice of Results |
| 16th Jul 2018 5:33 pm |
RNS |
Holding(s) in Company |
| 10th Jul 2018 7:00 am |
RNS |
Pre-Clinical Study in Atopic Dermatitis |
| 4th Jul 2018 7:00 am |
RNS |
Instructions for Exchanging Ordinary Shares |
| 4th Jul 2018 7:00 am |
RNS |
SEC registration effective NASDAQ listing approved |
| 14th Jun 2018 10:54 am |
RNS |
Result of AGM |
| 31st May 2018 7:00 am |
RNS |
Realm to Present at June Investor Conferences |
| 24th May 2018 7:00 am |
RNS |
Enrollment complete for Phase 2 study of PR022 |
| 23rd May 2018 7:00 am |
RNS |
Filing with US SEC to Facilitate Nasdaq Listing |
| 21st May 2018 7:00 am |
RNS |
Data Presentation at IID 2018 |
| 2nd May 2018 12:39 pm |
RNS |
Annual Financial Report Available |
| 2nd May 2018 7:00 am |
RNS |
Final Results |
| 2nd May 2018 7:00 am |
RNS |
Realm Files Registration for Nasdaq Listing of ADS |
| 26th Apr 2018 2:32 pm |
RNS |
Notice of Results |
| 12th Mar 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 12th Mar 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 12th Mar 2018 7:00 am |
RNS |
Clinical Update including PR013 Phase II results |
| 8th Mar 2018 7:00 am |
RNS |
Presenting at Cowen Healthcare Conference |
| 27th Feb 2018 7:00 am |
RNS |
Patent portfolio strengthened with USPTO allowance |
| 20th Feb 2018 12:00 pm |
RNS |
Presentation at RBC Healthcare Conference |
| 16th Feb 2018 7:00 am |
RNS |
Block listing Interim Review |
| 15th Feb 2018 7:00 am |
RNS |
Clinical and Business Update |
| 2nd Jan 2018 7:00 am |
RNS |
Presents at 5th Annual Dermatology Summit |
| 15th Dec 2017 7:00 am |
RNS |
Director/PDMR Shareholding |
| 12th Dec 2017 7:00 am |
RNS |
First Patient Dosed in Phase 2 Study of PR013 |
| 5th Dec 2017 7:00 am |
RNS |
First Patient Dosed in Phase 2 Study of PR022 |
| 21st Nov 2017 7:00 am |
RNS |
Realm: Preclinical Data on PR022 Published |
| 17th Nov 2017 7:00 am |
RNS |
Directorate Change |
| 2nd Nov 2017 7:00 am |
RNS |
Realm Therapeutics to Present at BIO-Europe® 2017 |
| 30th Oct 2017 7:00 am |
RNS |
Realm Presents Data at ACAAI Scientific Meeting |
| 18th Oct 2017 7:00 am |
RNS |
Holding(s) in Company |
| 18th Oct 2017 7:00 am |
RNS |
Block Listing Application |
| 17th Oct 2017 6:28 pm |
RNS |
Holding(s) in Company |
| 16th Oct 2017 3:39 pm |
RNS |
Holding(s) in Company |
| 16th Oct 2017 7:00 am |
RNS |
Realm Therapeutics to speak at BIO Investor Forum |
| 13th Oct 2017 2:20 pm |
RNS |
Holding(s) in Company |
